ENVOY MEDICAL, INC.
Income Statement
| Line Item | Aug 2026 | Jun 2026 | May 2026 | Mar 2026 | Mar 2026 | Nov 2025 | Sep 2025 | Jul 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $51.0K | — | $39.0K | — | — | $42.0K | — |
| Cost of Revenue | — | $278.0K | — | $313.0K | — | — | $203.0K | — |
| Gross Profit | — | $-227.0K | — | $-274.0K | — | — | $-161.0K | — |
| Gross Margin | — | -445.1% | — | -702.6% | — | — | -383.3% | — |
| Operating Expenses | ||||||||
| Research & Development | — | $3.1M | — | $3.6M | — | — | $2.7M | — |
| SG&A Expense | — | $2.0M | — | $1.9M | — | — | $2.4M | — |
| Operating Income | — | $-5.6M | — | $-6.0M | — | — | $-5.7M | — |
| Operating Margin | — | -10,919.6% | — | -15,279.5% | — | — | -13,590.5% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | — | $-6.0M | — | $-4.4M | — | — | $-6.5M | — |
| Net Margin | — | -11,729.4% | — | -11,156.4% | — | — | -15,433.3% | — |
| EPS (Basic) | — | $-0.07 | — | $-0.08 | — | — | $-0.35 | — |
| EPS (Diluted) | — | $-0.07 | — | $-0.08 | — | — | $-0.35 | — |
| Shares Outstanding (Basic) | 77.2M | 104.0M | 76.9M | 68.9M | 76.9M | 28.8M | 21.9M | 21.5M |
| Shares Outstanding (Diluted) | 77.2M | 104.0M | 76.9M | 68.9M | 76.9M | 28.8M | 21.9M | 21.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |